Canada markets open in 8 hours 32 minutes

Aurinia Pharmaceuticals Inc. (AUPH)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
5.59-0.19 (-3.29%)
At close: 04:00PM EDT
5.59 -0.00 (-0.02%)
After hours: 07:58PM EDT
Show:
Income Statement
Balance Sheet
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Cash flows from operating activities
Net Income
-62,563
-78,020
-108,180
-180,966
-102,680
-
Depreciation & amortization
15,777
11,647
2,706
2,761
1,371
-
Stock based compensation
41,581
45,311
32,300
31,243
17,454
-
Change in working capital
-3,115
-5,608
-6,817
-21,633
4,520
-
Accounts receivable
-9,867
-10,606
1,927
-15,415
-650
-
Inventory
-8,932
-15,869
-9,072
-5,644
-13,927
-
Accounts Payable
10,917
13,394
699
4,076
-
-
Other working capital
-20,610
-34,179
-79,821
-159,193
-77,201
-
Other non-cash items
-173
-1,515
-1,612
9,998
9,477
-
Net cash provided by operating activites
-20,389
-33,461
-79,529
-157,692
-69,858
-
Cash flows from investing activities
Investments in property, plant and equipment
-221
-718
-292
-1,501
-7,343
-
Purchases of investments
-502,363
-523,500
-523,993
-438,958
-202,951
-
Sales/Maturities of investments
532,115
529,376
464,316
354,427
52,108
-
Other investing activites
-
-11,864
-663
-17,838
-
-
Net cash used for investing activites
17,667
-6,706
-60,632
-103,870
-158,186
-
Cash flows from financing activities
Debt repayment
-12,803
-10,025
0
0
-
-127
Common stock issued
-
0
0
196,740
187,732
-
Net cash used privided by (used for) financing activities
-21,820
-5,130
2,433
221,112
194,375
-
Net change in cash
-24,542
-45,297
-137,728
-40,450
-33,669
-
Cash at beginning of period
89,001
94,172
231,900
272,350
306,019
-
Cash at end of period
64,459
48,875
94,172
231,900
272,350
-
Free Cash Flow
Operating Cash Flow
-20,389
-33,461
-79,529
-157,692
-69,858
-
Capital Expenditure
-221
-718
-292
-1,501
-7,343
-
Free Cash Flow
-20,610
-34,179
-79,821
-159,193
-77,201
-